These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 22246647)
61. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918 [TBL] [Abstract][Full Text] [Related]
62. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard. Hardie AD; Kizziah MK; Rissing MS J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541 [TBL] [Abstract][Full Text] [Related]
63. Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values. Peters NH; Vincken KL; van den Bosch MA; Luijten PR; Mali WP; Bartels LW J Magn Reson Imaging; 2010 May; 31(5):1100-5. PubMed ID: 20432344 [TBL] [Abstract][Full Text] [Related]
64. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases. Piana G; Trinquart L; Meskine N; Barrau V; Beers BV; Vilgrain V J Hepatol; 2011 Jul; 55(1):126-32. PubMed ID: 21145857 [TBL] [Abstract][Full Text] [Related]
66. The role of ADC measurement in differential diagnosis of focal hepatic lesions. Onur MR; Çiçekçi M; Kayalı A; Poyraz AK; Kocakoç E Eur J Radiol; 2012 Mar; 81(3):e171-6. PubMed ID: 21353418 [TBL] [Abstract][Full Text] [Related]
67. Quantitative analysis of the diffusion-weighted steady-state free precession signal in vertebral bone marrow lesions. Biffar A; Baur-Melnyk A; Schmidt GP; Reiser MF; Dietrich O Invest Radiol; 2011 Oct; 46(10):601-9. PubMed ID: 21610504 [TBL] [Abstract][Full Text] [Related]
68. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042 [TBL] [Abstract][Full Text] [Related]
69. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Kwee TC; van Ufford HM; Beek FJ; Takahara T; Uiterwaal CS; Bierings MB; Ludwig I; Fijnheer R; Nievelstein RA Invest Radiol; 2009 Oct; 44(10):683-90. PubMed ID: 19724232 [TBL] [Abstract][Full Text] [Related]
70. 3 T MRI of hepatocellular carcinomas in patients with cirrhosis: does T2-weighted imaging provide added value? Guo L; Liang C; Yu T; Wang G; Li N; Sun H; Gao F; Liu C Clin Radiol; 2012 Apr; 67(4):319-28. PubMed ID: 22099524 [TBL] [Abstract][Full Text] [Related]
71. Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. Takeuchi M; Matsuzaki K; Nishitani H J Comput Assist Tomogr; 2010; 34(2):173-6. PubMed ID: 20351498 [TBL] [Abstract][Full Text] [Related]
72. Diffusion weighted imaging of pediatric and adolescent malignancies with regard to detection and delineation: initial experience. Alibek S; Cavallaro A; Aplas A; Uder M; Staatz G Acad Radiol; 2009 Jul; 16(7):866-71. PubMed ID: 19394872 [TBL] [Abstract][Full Text] [Related]
73. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Kim CK; Park BK; Park W; Kim SS Abdom Imaging; 2010 Apr; 35(2):246-52. PubMed ID: 19130116 [TBL] [Abstract][Full Text] [Related]
74. Breast diffusion-weighted MRI: comparison of tetrahedral versus orthogonal diffusion sensitization for detection and localization of mass lesions. Ueguchi T; Yamada S; Mihara N; Koyama Y; Sumikawa H; Tomiyama N J Magn Reson Imaging; 2011 Jun; 33(6):1375-81. PubMed ID: 21591006 [TBL] [Abstract][Full Text] [Related]
75. Role of diffusion weighted imaging and contrast-enhanced MRI in the evaluation of intrapelvic recurrence of gynecological malignant tumor. Kitajima K; Tanaka U; Ueno Y; Maeda T; Suenaga Y; Takahashi S; Deguchi M; Miyahara Y; Ebina Y; Yamada H; Tsurusaki M; Tamaki Y; Sugimura K PLoS One; 2015; 10(1):e0117411. PubMed ID: 25629156 [TBL] [Abstract][Full Text] [Related]
76. Differentiation of malignant from benign soft tissue tumours: use of additive qualitative and quantitative diffusion-weighted MR imaging to standard MR imaging at 3.0 T. Lee SY; Jee WH; Jung JY; Park MY; Kim SK; Jung CK; Chung YG Eur Radiol; 2016 Mar; 26(3):743-54. PubMed ID: 26080796 [TBL] [Abstract][Full Text] [Related]
77. [Combined T2-weighted and diffusion-weighted MR imaging for staging of rectal cancers]. Zhang CD; Zhang HM; Meng YK; Ye F; Jiang J; Ouyang H; Zhao XM; Zhou CW Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):46-51. PubMed ID: 29365417 [No Abstract] [Full Text] [Related]
78. On the utility of quantitative diffusion-weighted MR imaging as a tool in differentiation between malignant and benign thyroid nodules. Wu LM; Chen XX; Li YL; Hua J; Chen J; Hu J; Xu JR Acad Radiol; 2014 Mar; 21(3):355-63. PubMed ID: 24332602 [TBL] [Abstract][Full Text] [Related]
79. The detection and discrimination of malignant and benign focal hepatic lesions: T2 weighted vs diffusion-weighted MRI. Yang DM; Jahng GH; Kim HC; Jin W; Ryu CW; Nam DH; Lee YK; Park SY Br J Radiol; 2011 Apr; 84(1000):319-26. PubMed ID: 20959371 [TBL] [Abstract][Full Text] [Related]
80. Diffusion-Weighted Imaging with Two Different b-Values in Detection of Solid Focal Liver Lesions. Yang DW; Wang KY; Yao X; Ye HY; Jiang T; Liu Y; Gao JY; Chen M; Zhou C; Yang ZH Biomed Res Int; 2016; 2016():8128207. PubMed ID: 27019851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]